Article: Comprehensive review of SGLT2 inhibitors' efficacy through their diuretic mode of action in diabetic patients.
2023 Volume 14, Page(s) 1174692
Abstract: SGLT2 inhibitors (SGLT2i) are now the mainstay therapy for both diabetes and heart failure. ...
Abstract | SGLT2 inhibitors (SGLT2i) are now the mainstay therapy for both diabetes and heart failure. |
---|---|
MeSH term(s) | Humans ; Canagliflozin/therapeutic use ; Diabetes Mellitus, Type 2/complications ; Diabetes Mellitus, Type 2/drug therapy ; Diuretics/therapeutic use ; Glucosides/therapeutic use ; Heart Failure/complications ; Observational Studies as Topic ; Sodium-Glucose Transporter 2 Inhibitors/adverse effects |
Chemical Substances | Canagliflozin (0SAC974Z85) ; Diuretics ; Glucosides ; Sodium-Glucose Transporter 2 Inhibitors |
Language | English |
Publishing date | 2023-07-20 |
Publishing country | Switzerland |
Document type | Journal Article ; Review |
ZDB-ID | 2592084-4 |
ISSN | 1664-2392 |
ISSN | 1664-2392 |
DOI | 10.3389/fendo.2023.1174692 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.